September 26th 2025
The 100% tariff on imported drugs will pressure pharma companies to build manufacturing sites in the US or face significant costs.
An Integrated Approach to Shipping Liquid in Single-Use Systems
May 2nd 2018Increased use of single-use systems has led to a need to redefine safe, stable and integral systems for shipping biopharmaceuticals around the world. This article provides qualification data under international ASTM D4169 norms.
Transition From Clinical to Commercial Supply Chain-Regulatory Starting Materials
March 1st 2018The authors discuss expectations of regulators on the selection of drug substance regulatory starting materials (RSM) and the justification of their designation in the pharmaceutical supply chain, the scope of the RSMs' presentation required in regulatory filings, and how to mitigate and prepare for "push backs" in the event of a major objection to the sponsor's RSM designation.
MediLedger to Explore Use of Blockchain for DSCSA Compliance
October 4th 2017Genentech, AmerisourceBergen, and McKesson are providing pharma user requirements for a new project that will evaluate blockchain‘s potential in meeting requirements of the Drug Supply Chain Security Act, and preventing pharmaceutical counterfeiting.